ALK+ large B-cell lymphoma

{{Empty section|date=November 2021}}

Upregulation of ALK is mainly due to chromosomal translocation t(2;17), resulting in a fusion gene of CLTC with ALK, but can rarely be due to t(2;5), fusing NPM1 with ALK;{{rp|378}} the later is the usual finding in anaplastic large cell lymphoma (ALCL). The t(2;17) translocation occurs in less than 1% of cases of ALK+ ALCL, but has been identified in inflammatory myofibroblastic tumors.

There is no association with Epstein–Barr virus{{rp|378}} or HHV8, or immunosuppression.{{rp|378}} The cells are CD20 and CD30 negative,{{rp|306}} showing weak focal expression in 3% and 6% respectively.{{rp|378}} They are EMA and CD138 positive,{{rp|306}} showing 100% expression respectively.{{rp|378}}

The median age of diagnosis is approximately late thirties to early forties.{{rp|378}} The estimates of childhood disease vary (8%, 15%, 30%{{rp|378}}) but it can be seen at any age.{{rp|306}}

The disease usually arises in lymph nodes, particularly the neck, but extranodal involvement, including in the gastrointestinal tract, nasal cavity, ovary and brain, has been described. Morphologically, there are large immunoblast-like cells with large central nucleoli, often cellular clusters, with a predilection for the lymph node sinuses{{rp|378}}{{rp|306}} in a cohesive pattern that can suggest carcinoma cells.{{rp|378}}{{rp|306}}

Multiagent chemotherapy is given, and can result in long-term success, particularly in childhood{{rp|306}} but prognosis is generally poor,{{rp|378}} particularly in higher stage disease.

• Lymphoma

{{reflist|2|refs=

{{Cite book | last1=Armitage | first1=JO| last2= Mauch |first2=PM |last3=Harris |first3=NL |title=Non-Hodgkin Lymphomas| publisher=Lippincott Williams & Wilkins| year=2010 | chapter=Chapter 20|edition=2nd |isbn= 9780781791168|display-authors=etal}}

{{cite journal |vauthors=Beltran B, Castillo J, Salas R, etal |title=ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature |journal=J Hematol Oncol |volume=2 |pages=11 |year=2009 |pmid=19250532 |pmc=2651189 |doi=10.1186/1756-8722-2-11 |doi-access=free }}

{{cite journal |vauthors=Delsol G, Lamant L, Mariamé B, etal |title=A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation |journal=Blood |volume=89 |issue=5 |pages=1483–90 |year=1997 |doi=10.1182/blood.V89.5.1483 |pmid=9057627 |doi-access=free }}

{{Cite book | last1=Jaffe | first1=ES | last2=Harris |first2=NL |last3=Vardiman |first3=JW |last4=Campo |first4=E |last5=Arber |first5=DA|title=Hematopathology | publisher=Elsevier Saunders| year=2011 |edition=1st |isbn= 9780721600406}}

{{cite journal |vauthors=Laurent C, Do C, Gascoyne RD, etal |title=Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis |journal=J. Clin. Oncol. |volume=27 |issue=25 |pages=4211–6 |year=2009 |pmid=19636007 |doi=10.1200/JCO.2008.21.5020 }}

{{cite journal |vauthors=Morgan EA, Nascimento AF |title=Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphoma |journal=Adv Hematol |volume=2012 |pages=529572 |year=2012 |pmid=22474449 |pmc=3299366 |doi=10.1155/2012/529572 |doi-access=free }}

{{cite journal |vauthors=Murga-Zamalloa C, Lim MS |title=ALK-driven tumors and targeted therapy: focus on crizotinib |journal=Pharmgenomics Pers Med |volume=7 |pages=87–94 |year=2014 |pmid=24715763 |pmc=3977456 |doi=10.2147/PGPM.S37504 |doi-access=free }}

{{cite book |first1=Steven H. |last1=Swerdlow |author2=International Agency for Research on Cancer |author3=World Health Organization |title=WHO classification of tumours of haematopoietic and lymphoid tissues |url=http://apps.who.int/bookorders/anglais/detart1.jsp?codlan=1&codcol=70&codcch=4002 |archive-url=https://web.archive.org/web/20131012173547/http://apps.who.int/bookorders/anglais/detart1.jsp?codlan=1&codcol=70&codcch=4002 |url-status=dead |archive-date=October 12, 2013 |year=2008 |publisher=International Agency for Research on Cancer |edition=4th | volume=2 |series=World Health Organization classification of tumours |isbn=9789283224310}}

{{cite journal |vauthors=Xing X, Lin D, Ran W, Liu H |title=ALK-positive diffuse large B-cell lymphoma of the duodenum: A case report and review of the literature |journal=Exp Ther Med |volume=8 |issue=2 |pages=409–412 |year=2014 |pmid=25009592 |pmc=4079440 |doi=10.3892/etm.2014.1786 }}

}}

{{DEFAULTSORT:ALK large B-cell lymphoma}}

Category:Lymphoma